Trial intelligence / Profile preview

Bupropion-Enhanced CM for Cocaine Dependence

NCT02111798Phase 3Completed

Sponsor
Johns Hopkins University
Start
Jul 2014
Primary completion
May 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bupropion in cocaine dependence, sponsored by Johns Hopkins University. Started Jul 2014; status: completed.

02

Drugs

bupropion
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT02111798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02111798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call